Tositumomab Plus Stem Cell Transplant Induces Remission in Refractory B-Cell Lymphoma
15th Dec 2005, 23:45 GMT
Radioimmunotherapy with tositumomab plus stem cell transplantation induced long-term remissions in elderly patients with relapsed or refractory B-cell lymphoma. Medscape Medical News Linda Little
Tositumomab Plus Stem Cell Transplant Induces Remission in Refractory B-Cell Lymphoma related news:
- Genmab Announces Responses With HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma — StratWire - Business of Healthcare NewsFeed
- Pharmacyclics Announces Presentation and Publication of Preliminary Results Evaluating Xcytrin for the Treatment of Refractory B-cell Lymphomas — Laboratory News from StratCenter.com
- Researchers develop stem cell lines — KeralaNext: Health
- AnorMED announces 73% of cancer patients who failed prior chemotherapy mobilizations succeed in collecting enough stem cells for transplant in MOZOBIL compassionate use program — StratWire - Business of Healthcare NewsFeed
- Boy ready for holidays after stem cell donation — floridatoday.com - Local News
- Adding Radioimmunotherapy To Chemotherapy Reduces Relapse Risk In Mantle Cell Leukemia Patients — Medical News Today RSS/XML Feed
- Stem Cell Scientist Fear Reprisals ... from the Left?? — blog.bioethics.net
- Probe launched into stem cell pioneer's work — IOL: SciTech
- Stem Cell Therapy International Names Eminent Stem Cell Research Scientist Igor Katkov to Its Medical and Scientific Advisory Board — ArriveNet : Health
- Exciting Strides Being Made in Stem Cell Research — Neurology News from StratCenter.com
Latest news from Medscape Headlines:
- New Treatment for Ischemic Stroke on the Horizon
- Adding Bevacizumab to First-Line Lung Cancer Therapy Shows Potential
- Type 1 and 2 T Helper Cell-mediated Colitis
- Radiation Therapy for Chronic Vesicular Hand Dermatitis
- November 14, 2006: In the News
- Alcoholic Liver Disease-Pathophysiological Aspects and Risk Factors
- Overweight in Celiac Disease: Prevalence, Clinical Characteristics, and Effect of a Gluten-Free Diet
- Bleeding-Edge Benefits
- End-Stage Renal Disease and Drug-Eluting Stents: One Small Step Forward?
- November 13, 2006: In the News